Institute for Vascular Investigation and Treatment VIVIT

Feldkirch, Austria

Institute for Vascular Investigation and Treatment VIVIT

Feldkirch, Austria
SEARCH FILTERS
Time filter
Source Type

Clodi M.,Konventhospital der Barmherzigen Bruder Linz | Clodi M.,ICMR Institute for Cardiovascular and Metabolic Research | Abrahamian H.,Internistisches Zentrum | Drexel H.,Institute for Vascular Investigation and Treatment VIVIT | And 17 more authors.
Wiener Klinische Wochenschrift | Year: 2016

Hyperglycemia significantly contributes to micro- and macrovascular complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals. © 2016, Springer-Verlag Wien.


PubMed | Karl Landsteiner Institute For Stoffwechselerkrankungen Und Nephrologie, Medical University of Graz, 1. Medizinische Abteilung, Konventhospital der Barmherzigen Bruder Linz and 12 more.
Type: | Journal: Wiener klinische Wochenschrift | Year: 2016

Hyperglycemia significantly contributes to micro- and macrovascular complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.

Loading Institute for Vascular Investigation and Treatment VIVIT collaborators
Loading Institute for Vascular Investigation and Treatment VIVIT collaborators